Last 2,487 INR
Change Today +14.45 / 0.58%
Volume 3.8K
GLXO On Other Exchanges
Symbol
Exchange
Natl India
As of 7:05 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

glaxosmithkline pharmaceutic (GLXO) Snapshot

Open
2,500
Previous Close
2,473
Day High
2,504
Day Low
2,475
52 Week High
03/3/14 - 3,055
52 Week Low
08/28/13 - 2,160
Market Cap
210.7B
Average Volume 10 Days
7.1K
EPS TTM
56.87
Shares Outstanding
84.7M
EX-Date
04/3/14
P/E TM
43.7x
Dividend
50.00
Dividend Yield
2.01%
Current Stock Chart for GLAXOSMITHKLINE PHARMACEUTIC (GLXO)

Related News

No related news articles were found.

glaxosmithkline pharmaceutic (GLXO) Related Businessweek News

No Related Businessweek News Found

glaxosmithkline pharmaceutic (GLXO) Details

GlaxoSmithKline Pharmaceuticals Limited operates as research-based healthcare and pharmaceutical company worldwide. It manufactures, distributes, and trades prescription medicines for a range of therapeutic areas, including analgesic, anti-infective, anti-inflammatory, anti-parasitic, cardiovascular, dermatology, diabetes, endocrine, gastrointestinal, gynaecology, immunosupressants, nutritional, respiratory, CNS, and oncology diseases. The company also offers vaccines for the prevention of various diseases comprising hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, streptococcus pneumonia, and others. GlaxoSmithKline Pharmaceuticals Limited was founded in 1924 and is based in Mumbai, India.

5,034 Employees
Last Reported Date: 03/20/14
Founded in 1924

glaxosmithkline pharmaceutic (GLXO) Top Compensated Officers

Managing Director, Executive Director and Mem...
Total Annual Compensation: 26.1M
Senior Executive Director of Finance, Senior ...
Total Annual Compensation: 14.3M
Executive Director of Technical and Executive...
Total Annual Compensation: 7.0M
Executive Director of Human Resources and Exe...
Total Annual Compensation: 7.2M
Compensation as of Fiscal Year 2013.

glaxosmithkline pharmaceutic (GLXO) Key Developments

GlaxoSmithkline Pharmaceuticals Limited Reports Unaudited Standalone Earnings Results for the First Quarter Ended March 31, 2014

GlaxoSmithkline Pharmaceuticals Limited reported unaudited standalone earnings results for the first quarter ended March 31, 2014. For the quarter, the company's net sales were INR 5,998.5 million against INR 6,321.4 million a year ago. Profit from operations before other income and exceptional items were INR 1,033.5 million against INR 1,634.5 million a year ago. Profit from ordinary activities before tax was INR 1,482.3 million against INR 2,388.5 million a year ago. Net profit from ordinary activities was INR 965.4 million or INR 11.4 per basic and diluted share against INR 1,690.1 million or INR 20.0 per basic and diluted share a year ago.

GlaxoSmithkline Planning To Sell Thane Property

GlaxoSmithkline Pharmaceuticals Limited (BSE:500660) is planning to sell asset. The company is looking to sell its 60-acre property in Thane district. According to realty experts, the value of the land is in the range of INR 16 billion to INR 18 billion. GlaxoSmithKline Pharmaceuticals’ Chairman, DS Parekh said, “We are doing remediation of the soil and when it is almost over we will try and sell the land if we can find a buyer during the next one year.”

GlaxoSmithkline Pharmaceuticals Limited to Report Q1, 2014 Results on Apr 17, 2014

GlaxoSmithkline Pharmaceuticals Limited announced that they will report Q1, 2014 results on Apr 17, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GLXO:IN 2,487.20 INR +14.45

GLXO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GLXO.
View Industry Companies
 

Industry Analysis

GLXO

Industry Average

Valuation GLXO Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PHARMACEUTIC, please visit www.gsk-india.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.